Celldex Therapeutics, Inc. Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax
Celldex Therapeutics, Inc. (CLDX) had Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax of $5.00 thousand as of 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax · last filed 2021-08-05
- 2021-06-30: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $5.00K.
- 2021-03-31: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $6.00K.
- 2020-12-31: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $5.00K.
- 2020-09-30: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $23.00K.
| Period end | Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax |
|---|---|
| 2021-06-30 | $5.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $6.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $5.00K 10-Q · filed 2021-08-05 |
| 2020-09-30 | $23.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $10.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $16.00K 10-Q · filed 2020-05-06 |
| 2019-12-31 | $26.00K 10-K · filed 2021-03-29 |
| 2019-09-30 | $39.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $42.00K 10-Q · filed 2019-08-07 |
| 2019-03-31 | $7.00K 10-Q · filed 2019-05-07 |
| 2018-06-30 | $1.00K 10-Q · filed 2018-08-08 |
| 2018-03-31 | $2.00K 10-Q · filed 2018-05-10 |
| 2017-12-31 | $4.00K 10-K · filed 2019-03-07 |
| 2017-09-30 | $8.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | $9.00K 10-Q · filed 2017-08-08 |
| 2017-03-31 | $15.00K 10-Q · filed 2017-05-09 |
| 2016-12-31 | $13.00K 10-K · filed 2018-03-07 |
| 2016-09-30 | $52.00K 10-Q · filed 2016-11-07 |
| 2016-06-30 | $137.00K 10-Q · filed 2016-08-08 |
| 2016-03-31 | $117.00K 10-Q · filed 2016-05-05 |
| 2015-12-31 | $31.00K 10-K · filed 2017-03-14 |
| 2015-09-30 | $120.00K 10-Q · filed 2015-11-05 |
| 2015-06-30 | $73.00K 10-Q · filed 2015-08-10 |
| 2015-03-31 | $118.00K 10-Q · filed 2015-04-29 |
| 2014-12-31 | $88.00K 10-K/A · filed 2016-02-25 |
| 2014-09-30 | $132.00K 10-Q · filed 2014-11-05 |
| 2013-12-31 | $104.00K 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |